Editorial Independence:
▪️ This guideline was developed without any external funding.
▪️ All the guideline development group members have declared that they do not have any competing interests.
No |
Guidelines name |
year of pblication |
The Organizaion |
Age of Demography |
1 |
ICAR (international consensus statement allergy and rhinology)- ESBS |
2019 |
the American Rhinologic Society and the American Academy of Otolaryngic Allergy |
Adult and children |
2 |
Europian position paper on endoscopic management of tumors of the nose, PNS and skull base |
2015 |
European Rhinologic Society |
Adult and children |
3 |
A systematic review of secondery CSF rhinorrhea (2017) |
2017 |
Department of Otolaryngology—Head and Neck Surgery, Mount Sinai Medical Center, |
Adult and children |
4 |
The endoscopic endonasal repair for iatrogenic and non iatrigenic CSF leaks and encephaloceles of the anterior cranial fossa (2014 |
2014 |
Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA |
Adult and children |
(Table 1): assessment of currency table
Criteria |
Guideline A (ICAR-ESBS) |
Guideline B (EPOS) |
Guideline C A systematic review of secondery CSF rhinorrhea (2017), Mount Sinai Medical Center |
Guideline D The endoscopic endonasal repair for iatrogenic and non iatrigenic CSF leaks and encephaloceles of the anterior cranial fossa (2014) Weill Cornell Medical College, New York |
Credibility |
9 |
8 |
7 |
7 |
Observability |
9 |
8 |
7 |
7 |
Relevance |
9 |
9 |
7 |
6 |
Relative advantage |
9 |
6 |
6 |
7 |
Easy to install and understand |
9 |
8 |
8 |
7 |
Compatibility |
8 |
8 |
8 |
8 |
Testability |
8 |
8 |
8 |
8 |
Total Score |
61 |
55 |
51 |
52 |
(Table 2) assessment of content table
Guideline A (ICAR-ESBS) |
Guideline B (EPOS) |
Guideline C A systematic review of secondery CSF rhinorrhea (2017), Mount Sinai Medical Center |
Guideline D The endoscopic endonasal repair for iatrogenic and non iatrigenic CSF leaks and encephaloceles of the anterior cranial fossa (2014Weill Cornell Medical College, New York |
|
Transparency |
A |
A |
B |
B |
Conflict of interest |
B |
B |
B |
B |
Development group |
B |
C |
C |
c |
Systematic revie |
A |
A |
A |
B |
Grading of evidence |
A |
A |
B |
B |
recommendation |
A |
B |
C |
C |
External review |
B |
NR |
NR |
NR |
updating |
B |
B |
B |
B |
Annex 3: The risks and benefits of added and/or modified statements